Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.068 | 0.7 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.085 | 0.7 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.079 | 0.7 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |